Literature DB >> 10859434

Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-Year Observation period: serotyping, macrorestriction analysis of Genomic DNA and antibiotic susceptibilities.

W H Traub1, D Bauer.   

Abstract

During a 10-year surveillance period, a total of 2,359 isolates comprising the genus Acinetobacter were recovered and identified presumptively with phenotypic tests. Genospecies 3 was the most common (n = 1,053), followed by genospecies 13 (n = 352), Acinetobacter baumannii (n = 335), Acinetobacter Iwoffi (n = 162), and genospecies 14 (n = 97); 100 isolates (4.2%) were categorized as questionable Acinetobacter. There were 34 clusters of putative nosocomial cross-infection due either to genospecies 3 (n = 16), A. baumannii (n = 10) or genospecies 13 (n = 8). Apart from 3 clusters due to two multiple-antibiotic-resistant strains of genospecies 13 and one strain of A. baumannii, respectively, there was no significant increase of antibiotic resistance discernible during the decade-long period of Acinetobacter surveillance. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859434     DOI: 10.1159/000007300

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  9 in total

1.  The increasing role of Acinetobacter species as nosocomial pathogens.

Authors:  Eugénie Bergogne-Bérézin
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

2.  Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors:  A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

3.  Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing.

Authors:  Paul G Higgins; Katharina Janssen; Maximilian M Fresen; Hilmar Wisplinghoff; Harald Seifert
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

4.  Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

Authors:  P J van den Broek; T J K van der Reijden; E van Strijen; A V Helmig-Schurter; A T Bernards; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

5.  Genetic variability among ampC genes from acinetobacter genomic species 3.

Authors:  Alejandro Beceiro; Astrid Pérez; Felipe Fernández-Cuenca; Luis Martínez-Martínez; Alvaro Pascual; Jordi Vila; Jesús Rodríguez-Baño; Jose Miguel Cisneros; Jerónimo Pachón; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

6.  Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii.

Authors:  Edward Geisinger; Ralph R Isberg
Journal:  PLoS Pathog       Date:  2015-02-13       Impact factor: 6.823

7.  Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme.

Authors:  Dalong Hu; Bin Liu; Lenie Dijkshoorn; Lei Wang; Peter R Reeves
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 8.  The Acinetobacter baumannii group: a systemic review.

Authors:  Hua-Zhong Zhang; Jin-Song Zhang; Li Qiao
Journal:  World J Emerg Med       Date:  2013

9.  Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive.

Authors:  Kelly L Wyres; Sarah M Cahill; Kathryn E Holt; Ruth M Hall; Johanna J Kenyon
Journal:  Microb Genom       Date:  2020-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.